Why 10x Genomics is on investors’ radar today 10x Genomics (TXG) has drawn fresh attention after recent trading, with the ...

PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report ...

Doximity, 10x Genomics and Omnicell stand out in the Medical Info Systems sector, leveraging AI, telehealth, and workflow ...

Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with Dana-Farber ...

The partners are launching ImmuneScape, a multiomics program using spatial and single-cell sequencing to study immune drivers ...

CareDx Inc. has entered a strategic collaboration with 10x Genomics to establish ImmuneScape, a multiomics research initiative.

PLEASANTON, Calif., March 3, 2025 /PRNewswire/ — 10x Genomics (Nasdaq: TXG), a leader in single-cell and spatial biology, today provided an update on its patent litigation with Parse Biosciences.

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look ...

View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-reports-first-quarter-2025-financial-results-302450468.html SOURCE ...

View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-reports-second-quarter-2025-financial-results-302524722.html SOURCE ...